{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:00:20Z","timestamp":1793638820282,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022811","name":"Fondazione Nadia Valsecchi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1245\/s10434-024-15105-2","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T18:02:26Z","timestamp":1709920946000},"page":"4084-4095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a \u201cBiological R2 Definition\u201d"],"prefix":"10.1245","volume":"31","author":[{"given":"Giulio","family":"Belfiori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pagnanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Aleotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Riccardo","family":"Camisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Schiavo Lena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Tamburrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Reni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"issue":"1","key":"15105_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin."},{"issue":"3 SUPPL","key":"15105_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.surg.2012.05.020","volume":"152","author":"CR Ferrone","year":"2012","unstructured":"Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al. Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surg (United States). 2012;152(3 SUPPL):43\u20139. https:\/\/doi.org\/10.1016\/j.surg.2012.05.020.","journal-title":"Surg (United States)."},{"issue":"3","key":"15105_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00000658-199603000-00007","volume":"223","author":"KC Conlon","year":"1996","unstructured":"Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathologic analysis of 5-year survivors. Ann Surg. 1996;223(3):273\u20139. https:\/\/doi.org\/10.1097\/00000658-199603000-00007.","journal-title":"Ann Surg."},{"issue":"5","key":"15105_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jamcollsurg.2004.01.008","volume":"198","author":"SP Cleary","year":"2004","unstructured":"Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004;198(5):722\u201331. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2004.01.008.","journal-title":"J Am Coll Surg."},{"issue":"3","key":"15105_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/SLA.0b013e3181613142","volume":"247","author":"T Schnelldorfer","year":"2008","unstructured":"Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma is cure possible? Ann Surg. 2008;247(3):456\u201362. https:\/\/doi.org\/10.1097\/SLA.0b013e3181613142.","journal-title":"Ann Surg."},{"issue":"10","key":"15105_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00595-020-02028-0","volume":"50","author":"RJ Torphy","year":"2020","unstructured":"Torphy RJ, Fujiwara Y, Schulick RD. Pancreatic cancer treatment: better, but a long way to go. Surg Today. 2020;50(10):1117\u201325. https:\/\/doi.org\/10.1007\/s00595-020-02028-0.","journal-title":"Surg Today."},{"issue":"6","key":"15105_CR7","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","volume":"269","author":"VP Groot","year":"2019","unstructured":"Groot VP, Gemenetzis G, Blair AB, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(6):1154\u201362. https:\/\/doi.org\/10.1097\/SLA.0000000000002734.","journal-title":"Ann Surg."},{"issue":"25","key":"15105_CR8","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/nejmoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379(25):2395\u2013406. https:\/\/doi.org\/10.1056\/nejmoa1809775.","journal-title":"N Engl J Med."},{"issue":"13","key":"15105_CR9","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1245\/s10434-021-10401-7","volume":"28","author":"G Belfiori","year":"2021","unstructured":"Belfiori G, Crippa S, Francesca A, et al. Long-term survivors after upfront resection for pancreatic ductal adenocarcinoma: an actual 5-year analysis of disease-specific and post-recurrence survival. Ann Surg Oncol. 2021;28(13):8249\u201360. https:\/\/doi.org\/10.1245\/s10434-021-10401-7.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"15105_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/sla.0000000000004147","volume":"275","author":"O Strobel","year":"2020","unstructured":"Strobel O, Lorenz P, Hinz U, et al. Actual five-year survival after upfront resection for pancreatic ductal adenocarcinoma. Ann Surg. 2020;275(5):1\u201310. https:\/\/doi.org\/10.1097\/sla.0000000000004147.","journal-title":"Ann Surg."},{"issue":"11","key":"15105_CR11","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, Van Dam JL, Suker M, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial. J Clin Oncol. 2022;40(11):1220\u201330. https:\/\/doi.org\/10.1200\/JCO.21.02233.","journal-title":"J Clin Oncol."},{"issue":"10","key":"15105_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamasurg.2019.2277","volume":"154","author":"L Maggino","year":"2019","unstructured":"Maggino L, Malleo G, Marchegiani G, et al. Outcomes of Primary chemotherapy for borderline resectable and locally advanced pancreatic ductal adenocarcinoma. JAMA Surg. 2019;154(10):932\u201342. https:\/\/doi.org\/10.1001\/jamasurg.2019.2277.","journal-title":"JAMA Surg."},{"issue":"6","key":"15105_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S2468-1253(18)30081-5","volume":"3","author":"M Reni","year":"2018","unstructured":"Reni M, Balzano G, Zanon S, et al. Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2\u20133 trial. Lancet Gastroenterol Hepatol. 2018;3(6):413\u201323. https:\/\/doi.org\/10.1016\/S2468-1253(18)30081-5.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"6","key":"15105_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1200\/JCO.2013.50.7657","volume":"32","author":"JW Valle","year":"2014","unstructured":"Valle JW, Palmer D, Jackson R, et al. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol. 2014;32(6):504\u201312. https:\/\/doi.org\/10.1200\/JCO.2013.50.7657.","journal-title":"J Clin Oncol."},{"issue":"3","key":"15105_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jso.26510","volume":"124","author":"S Narayanan","year":"2021","unstructured":"Narayanan S, AlMasri S, Zenati M, et al. Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma. J Surg Oncol. 2021;124(3):308\u201316. https:\/\/doi.org\/10.1002\/jso.26510.","journal-title":"J Surg Oncol."},{"issue":"7660","key":"15105_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jamcollsurg.2007.12.020.BORDERLINE","volume":"546","author":"MHG Katz","year":"2017","unstructured":"Katz MHG, Pisters PWT, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 2017;546(7660):651\u20135. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2007.12.020.BORDERLINE.","journal-title":"J Am Coll Surg."},{"issue":"55","key":"15105_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.6004\/jnccn.2019.5007","volume":"17","author":"MA Tempero","year":"2019","unstructured":"Tempero MA. NCCN guidelines updates: pancreatic cancer. J Natl Compr Canc Netw. 2019;17(55):603\u20135. https:\/\/doi.org\/10.6004\/jnccn.2019.5007.","journal-title":"J Natl Compr Canc Netw."},{"issue":"12","key":"15105_CR18","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1245\/s10434-009-0670-7","volume":"16","author":"G Barugola","year":"2009","unstructured":"Barugola G, Partelli S, Marcucci S, et al. Resectable pancreatic cancer: Who really benefits from resection? Ann Surg Oncol. 2009;16(12):3316\u201322. https:\/\/doi.org\/10.1245\/s10434-009-0670-7.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"15105_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/jso.25288","volume":"118","author":"G Gemenetzis","year":"2018","unstructured":"Gemenetzis G, Groot VP, Blair AB, et al. Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma. J Surg Oncol. 2018;118(8):1277\u201384. https:\/\/doi.org\/10.1002\/jso.25288.","journal-title":"J Surg Oncol."},{"key":"15105_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.03.229","author":"D Tamburrino","year":"2023","unstructured":"Tamburrino D, Belfiori G, Andreasi V, et al. Pancreatectomy with venous vascular resection for pancreatic cancer: impact of types of vein resection on timing and pattern of recurrence. Eur J Surg Oncol. 2023. https:\/\/doi.org\/10.1016\/j.ejso.2023.03.229.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"15105_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic in longitudinal studies: development. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis."},{"issue":"1","key":"15105_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","volume":"18","author":"S Isaji","year":"2018","unstructured":"Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1):2\u201311. https:\/\/doi.org\/10.1016\/j.pan.2017.11.011.","journal-title":"Pancreatology."},{"issue":"6","key":"15105_CR23","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/jso.26103","volume":"122","author":"JK Kim","year":"2020","unstructured":"Kim JK, DePeralta DK, Ogami T, et al. Cancer outcomes are independent of preoperative CA 19\u20139 in anatomically resectable pancreatic ductal adenocarcinoma: a retrospective cohort analysis. J Surg Oncol. 2020;122(6):1074\u201383. https:\/\/doi.org\/10.1002\/jso.26103.","journal-title":"J Surg Oncol."},{"issue":"4","key":"15105_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845\u20137. https:\/\/doi.org\/10.1245\/s10434-017-6025-x.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"15105_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/bjs.8734","volume":"99","author":"CS Verbeke","year":"2012","unstructured":"Verbeke CS, Gladhaug IP. Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg. 2012;99(8):1036\u201349. https:\/\/doi.org\/10.1002\/bjs.8734.","journal-title":"Br J Surg."},{"issue":"3","key":"15105_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surg (United States). 2017;161(3):584\u201391. https:\/\/doi.org\/10.1016\/j.surg.2016.11.014.","journal-title":"Surg (United States)."},{"issue":"2","key":"15105_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"issue":"5","key":"15105_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.surg.2006.12.013","volume":"141","author":"TM Pawlik","year":"2007","unstructured":"Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141(5):610\u20138. https:\/\/doi.org\/10.1016\/j.surg.2006.12.013.","journal-title":"Surgery."},{"issue":"1","key":"15105_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07182-9","volume":"20","author":"DT Pointer","year":"2020","unstructured":"Pointer DT, Roife D, Powers BD, et al. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. BMC Cancer. 2020;20(1):1\u201311. https:\/\/doi.org\/10.1186\/s12885-020-07182-9.","journal-title":"BMC Cancer."},{"issue":"3","key":"15105_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/COC.0000000000000263","volume":"41","author":"M Alagappan","year":"2018","unstructured":"Alagappan M, Pollom EL, Von Eyben R, et al. Albumin and neutrophil-lymphocyte ratio (NLR) predict survival in patients with pancreatic adenocarcinoma treated with SBRT. Am J Clin Oncol Cancer Clin Trials. 2018;41(3):242\u20137. https:\/\/doi.org\/10.1097\/COC.0000000000000263.","journal-title":"Am J Clin Oncol Cancer Clin Trials."},{"issue":"11","key":"15105_CR31","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united states. Cancer Res. 2014;74(11):2913\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155.","journal-title":"Cancer Res."},{"key":"15105_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2021.04.004","author":"S Crippa","year":"2021","unstructured":"Crippa S, Belfiori G, Bissolati M, et al. Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology. Hpb. 2021. https:\/\/doi.org\/10.1016\/j.hpb.2021.04.004.","journal-title":"Hpb."},{"issue":"12","key":"15105_CR33","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1245\/s10434-019-07602-6","volume":"26","author":"AM Altman","year":"2019","unstructured":"Altman AM, Wirth K, Marmor S, et al. Completion of adjuvant chemotherapy after upfront surgical resection for pancreatic cancer is uncommon yet associated with improved survival. Ann Surg Oncol. 2019;26(12):4108\u201316. https:\/\/doi.org\/10.1245\/s10434-019-07602-6.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"15105_CR34","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1001\/jamaoncol.2020.3537","volume":"6","author":"S Van Roessel","year":"2020","unstructured":"Van Roessel S, Van Veldhuisen E, Klompmaker S, et al. Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX Treatment. JAMA Oncol. 2020;6(11):1733\u201340. https:\/\/doi.org\/10.1001\/jamaoncol.2020.3537.","journal-title":"JAMA Oncol."},{"issue":"1\u20132","key":"15105_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148(1\u20132):349\u201361. https:\/\/doi.org\/10.1016\/j.cell.2011.11.025.","journal-title":"Cell."},{"issue":"19","key":"15105_CR36","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/nejmoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817\u201325. https:\/\/doi.org\/10.1056\/nejmoa1011923.","journal-title":"N Engl J Med."},{"issue":"6","key":"15105_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S1470-2045(16)00172-8","volume":"17","author":"M Suker","year":"2016","unstructured":"Suker M, Beumer BR, Sadot E, et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17(6):801\u201310. https:\/\/doi.org\/10.1016\/S1470-2045(16)00172-8.","journal-title":"Lancet Oncol."},{"issue":"6","key":"15105_CR38","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.pan.2021.04.010","volume":"21","author":"J Ge","year":"2021","unstructured":"Ge J, Tao M, Li L, et al. Nomogram and competing risk model to predict recurrence after curative surgical resection of PDAC. Pancreatology. 2021;21(6):1102\u201311. https:\/\/doi.org\/10.1016\/j.pan.2021.04.010.","journal-title":"Pancreatology."},{"key":"15105_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040497","author":"DJ Birnbaum","year":"2019","unstructured":"Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E. Head and body\/tail pancreatic carcinomas are not the same tumors. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11040497.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"15105_CR40","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jcmm.16281","volume":"25","author":"X Zhang","year":"2021","unstructured":"Zhang X, Feng S, Wang Q, et al. Comparative genomic analysis of head and body\/tail of pancreatic ductal adenocarcinoma at early and late stages. J Cell Mol Med. 2021;25(3):1750\u20138. https:\/\/doi.org\/10.1111\/jcmm.16281.","journal-title":"J Cell Mol Med."},{"issue":"5","key":"15105_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.21037\/jgo.2018.08.06","volume":"9","author":"C Takahashi","year":"2018","unstructured":"Takahashi C, Shridhar R, Huston J, Meredith K. Correlation of tumor size and survival in pancreatic cancer. J Gastrointest Oncol. 2018;9(5):910\u201321. https:\/\/doi.org\/10.21037\/jgo.2018.08.06.","journal-title":"J Gastrointest Oncol."},{"issue":"1","key":"15105_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-86779-x","volume":"11","author":"MC Rittmann","year":"2021","unstructured":"Rittmann MC, Hussung S, Braun LM, et al. Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma. Sci Rep. 2021;11(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-86779-x.","journal-title":"Sci Rep."},{"issue":"11","key":"15105_CR43","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1158\/1078-0432.CCR-16-1467","volume":"23","author":"KE Poruk","year":"2017","unstructured":"Poruk KE, Blackford AL, Weiss MJ, et al. Circulating tumor cells expressing markers of tumor-initiating cells predict poor survival and cancer recurrence in patients with pancreatic ductal adenocarcinoma. Clin Cancer Res. 2017;23(11):2681\u201390. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1467.","journal-title":"Clin Cancer Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15105-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T13:07:11Z","timestamp":1715087231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["15105"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15105-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}